Foamix Pharmaceuticals Current Ratio 2014-2019 | FOMX

Foamix Pharmaceuticals current ratio from 2014 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Foamix Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.07B $0.01B 5.09
2019-03-31 $0.09B $0.01B 9.03
2018-12-31 $0.10B $0.01B 9.66
2018-09-30 $0.11B $0.01B 12.40
2018-06-30 $0.06B $0.02B 3.72
2018-03-31 $0.05B $0.01B 4.54
2017-12-31 $0.07B $0.01B 6.80
2017-09-30 $0.08B $0.01B 10.02
2017-06-30 $0.10B $0.01B 9.03
2017-03-31 $0.11B $0.01B 15.14
2016-12-31 $0.12B $0.01B 22.20
2016-09-30 $0.13B $0.01B 18.88
2016-06-30 $0.08B $0.00B 26.29
2016-03-31 $0.06B $0.00B 18.94
2015-12-31 $0.06B $0.00B 14.08
2015-09-30 $0.06B $0.00B 19.52
2015-06-30 $0.07B $0.00B 23.29
2015-03-31 $0.04B $0.00B 12.85
2014-12-31 $0.05B $0.00B 23.89
2014-09-30 $0.05B $0.00B 16.51
2014-06-30 $0.00B 0.00
2014-03-31 $0.00B 0.00
2013-12-31 $0.00B 0.00
2013-09-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.212B $0.004B
Foamix Pharmaceuticals Ltd. is a specialty pharmaceutical company. It develops and commercializes foam-based formulations acne, impetigo, and other skin conditions. The Company's lead product candidates include FMX101, which has completed a dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has completed a Phase II clinical trial for the treatment of impetigo. It has operations primarily in the United States, Germany, and Israel. Foamix Pharmaceuticals Ltd. is headquartered in Rehovot, Israel.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $61.501B 9.72
Zoetis (ZTS) United States $55.741B 33.34
Astellas Pharma (ALPMY) Japan $32.908B 15.68
Eisai (ESALY) Japan $19.704B 37.99
Merck (MKGAF) Germany $15.591B 21.27
Grifols, S.A (GRFS) Spain $14.707B 18.76
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.209B 481.96
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.999B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $7.969B 16.14
Sage Therapeutics (SAGE) United States $7.456B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.404B 9.46
Catalent (CTLT) United States $7.294B 29.67
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hypermarcas (HYPMY) Brazil $5.399B 19.41
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.071B 93.35
United Therapeutics (UTHR) United States $3.991B 0.00
Nektar Therapeutics (NKTR) United States $3.677B 0.00
Evotec AG (EVTCY) Germany $3.178B 43.51
FibroGen (FGEN) United States $3.077B 90.77
Taro Pharmaceutical Industries (TARO) Israel $2.926B 10.69
PTC Therapeutics (PTCT) United States $2.545B 0.00
Portola Pharmaceuticals (PTLA) United States $2.183B 0.00
Tilray (TLRY) Canada $2.140B 0.00
Zogenix (ZGNX) United States $1.952B 0.00
Xencor (XNCR) United States $1.923B 58.45
Corcept Therapeutics (CORT) United States $1.820B 22.13
Pacira Pharmaceuticals (PCRX) United States $1.812B 53.72
Ironwood Pharmaceuticals (IRWD) United States $1.742B 55.55
Heron Therapeutics (HRTX) United States $1.643B 0.00
USANA Health Sciences (USNA) United States $1.627B 17.36
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.216B 20.06
Radius Health (RDUS) United States $1.161B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.003B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.995B 0.00
Karyopharm Therapeutics (KPTI) United States $0.959B 0.00
Endo (ENDP) Ireland $0.932B 1.71
ArQule (ARQL) United States $0.930B 0.00
Aerie Pharmaceuticals (AERI) United States $0.882B 0.00
Dova Pharmaceuticals (DOVA) United States $0.808B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.793B 5.41
TherapeuticsMD (TXMD) United States $0.773B 0.00
Organogenesis Holdings (ORGO) United States $0.695B 0.00
Collegium Pharmaceutical (COLL) United States $0.637B 0.00
Flexion Therapeutics (FLXN) United States $0.616B 0.00
Translate Bio (TBIO) United States $0.575B 0.00
ChemoCentryx (CCXI) United States $0.544B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.517B 0.00
Concordia (CXRXF) Canada $0.500B 0.00
ImmunoGen (IMGN) United States $0.487B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.482B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.466B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.459B 0.00
Dermira (DERM) United States $0.439B 0.00
Akebia Therapeutics (AKBA) United States $0.435B 0.00
Siga Technologies (SIGA) United States $0.421B 9.61
Indivior (INVVY) United States $0.413B 1.49
OptiNose (OPTN) United States $0.408B 0.00
DURECT (DRRX) United States $0.404B 0.00
Recro Pharma (REPH) United States $0.392B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.387B 0.00
Innate Pharma SA (IPHYF) France $0.385B 0.00
Ardelyx (ARDX) United States $0.379B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.365B 15.76
Lannett Co Inc (LCI) United States $0.354B 4.11
Molecular Templates (MTEM) United States $0.341B 0.00
Harpoon Therapeutics (HARP) United States $0.326B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.285B 0.00
GlycoMimetics (GLYC) United States $0.256B 0.00
Rafael Holdings (RFL) United States $0.255B 0.00
Xeris Pharmaceuticals (XERS) United States $0.228B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.211B 0.00
KalVista Pharmaceuticals (KALV) United States $0.204B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.184B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.183B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.180B 31.10
Calithera Biosciences (CALA) United States $0.169B 0.00
CV Sciences (CVSI) United States $0.169B 0.00
Concert Pharmaceuticals (CNCE) United States $0.165B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
Jounce Therapeutics (JNCE) United States $0.156B 2.09
Aquestive Therapeutics (AQST) United States $0.150B 0.00
CannTrust Holdings (CTST) Canada $0.147B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.147B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.142B 0.00
Redhill Biopharma (RDHL) Israel $0.140B 0.00
Ocular Therapeutix (OCUL) United States $0.138B 0.00
MEI Pharma (MEIP) United States $0.136B 0.00
IMV INC (IMV) Canada $0.135B 0.00
Cardiome Pharma (CORV) Canada $0.121B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.094B 0.00
Majesco Entertainment (PTE) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 33.66
Oasmia Pharmaceutical AB (OASMY) Sweden $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.083B 0.00
Otonomy (OTIC) United States $0.080B 0.00
Aclaris Therapeutics (ACRS) United States $0.078B 0.00
MediWound (MDWD) Israel $0.078B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.073B 0.00
Generex Biotechnology (GNBT) United States $0.072B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.064B 0.00
Natural Alternatives (NAII) United States $0.063B 9.55
Adamis Pharmaceuticals (ADMP) United States $0.060B 0.00
Genocea Biosciences (GNCA) United States $0.060B 0.00
Medicure (MCUJF) Canada $0.058B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
IntelGenx Technologies (IGXT) Canada $0.055B 0.00
AgeX Therapeutics (AGE) United States $0.055B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
Nivalis Therapeutics (ALPN) United States $0.053B 0.00
Infinity Pharmaceuticals (INFI) United States $0.053B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.051B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Capnia (SLNO) United States $0.045B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.039B 0.00
Jaguar Animal Health (JAGX) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
India Globalization Capital (IGC) United States $0.035B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
Mast Therapeutics (SVRA) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Bio-Path Holdings (BPTH) United States $0.032B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Melinta Therapeutics (MLNT) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.026B 0.00
IsoRay (ISR) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Lipocine (LPCN) United States $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.014B 16.76
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
Vical (BBI) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00